These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
479 related articles for article (PubMed ID: 33924360)
1. The Methyl Ester of 2-Cyano-3,12-Dioxooleana-1,9-Dien-28-Oic Acid Reduces Endometrial Lesions Development by Modulating the NFkB and Nrf2 Pathways. Siracusa R; D'Amico R; Cordaro M; Peritore AF; Genovese T; Gugliandolo E; Crupi R; Impellizzeri D; Cuzzocrea S; Fusco R; Di Paola R Int J Mol Sci; 2021 Apr; 22(8):. PubMed ID: 33924360 [TBL] [Abstract][Full Text] [Related]
2. Therapeutic Effects of Nrf2 Activation by Bardoxolone Methyl in Chronic Heart Failure. Tian C; Gao L; Zhang A; Hackfort BT; Zucker IH J Pharmacol Exp Ther; 2019 Dec; 371(3):642-651. PubMed ID: 31601682 [TBL] [Abstract][Full Text] [Related]
3. Therapeutic effects of C-28 methyl ester of 2-cyano-3,12-dioxoolean-1,9-dien-28-oic acid (CDDO-Me; bardoxolone methyl) on radiation-induced lung inflammation and fibrosis in mice. Wang YY; Zhang CY; Ma YQ; He ZX; Zhe H; Zhou SF Drug Des Devel Ther; 2015; 9():3163-78. PubMed ID: 26124639 [TBL] [Abstract][Full Text] [Related]
4. CDDO-Me Inhibits Microglial Activation and Monocyte Infiltration by Abrogating NFκB- and p38 MAPK-Mediated Signaling Pathways Following Status Epilepticus. Kim JE; Park H; Lee JE; Kang TC Cells; 2020 May; 9(5):. PubMed ID: 32370011 [TBL] [Abstract][Full Text] [Related]
5. The synthetic triterpenoid RTA dh404 (CDDO-dhTFEA) restores Nrf2 activity and attenuates oxidative stress, inflammation, and fibrosis in rats with chronic kidney disease. Aminzadeh MA; Reisman SA; Vaziri ND; Khazaeli M; Yuan J; Meyer CJ Xenobiotica; 2014 Jun; 44(6):570-8. PubMed ID: 24195589 [TBL] [Abstract][Full Text] [Related]
6. CDDO-Im exerts antidepressant-like effects via the Nrf2/ARE pathway in a rat model of post-stroke depression. Hou X; Liu H; Ping Y; Zhang F; Zhi L; Jiang X; Zhang F; Song C; Zhang Z; Song J Brain Res Bull; 2021 Aug; 173():74-81. PubMed ID: 33991607 [TBL] [Abstract][Full Text] [Related]
7. Preclinical evaluation of targeting the Nrf2 pathway by triterpenoids (CDDO-Im and CDDO-Me) for protection from LPS-induced inflammatory response and reactive oxygen species in human peripheral blood mononuclear cells and neutrophils. Thimmulappa RK; Fuchs RJ; Malhotra D; Scollick C; Traore K; Bream JH; Trush MA; Liby KT; Sporn MB; Kensler TW; Biswal S Antioxid Redox Signal; 2007 Nov; 9(11):1963-70. PubMed ID: 17822364 [TBL] [Abstract][Full Text] [Related]
9. A synthetic triterpenoid, CDDO-Me, inhibits IkappaBalpha kinase and enhances apoptosis induced by TNF and chemotherapeutic agents through down-regulation of expression of nuclear factor kappaB-regulated gene products in human leukemic cells. Shishodia S; Sethi G; Konopleva M; Andreeff M; Aggarwal BB Clin Cancer Res; 2006 Mar; 12(6):1828-38. PubMed ID: 16551868 [TBL] [Abstract][Full Text] [Related]
11. Prevention of murine lupus nephritis by targeting multiple signaling axes and oxidative stress using a synthetic triterpenoid. Wu T; Ye Y; Min SY; Zhu J; Khobahy E; Zhou J; Yan M; Hemachandran S; Pathak S; Zhou XJ; Andreeff M; Mohan C Arthritis Rheumatol; 2014 Nov; 66(11):3129-39. PubMed ID: 25047252 [TBL] [Abstract][Full Text] [Related]
12. Depletion of intracellular glutathione contributes to JNK-mediated death receptor 5 upregulation and apoptosis induction by the novel synthetic triterpenoid methyl-2-cyano-3, 12-dioxooleana-1, 9-dien-28-oate (CDDO-Me). Yue P; Zhou Z; Khuri FR; Sun SY Cancer Biol Ther; 2006 May; 5(5):492-7. PubMed ID: 16582599 [TBL] [Abstract][Full Text] [Related]
14. The triterpenoid 2-cyano-3,12-dioxooleana-1,9-dien-28-oic-acid methyl ester has potent anti-diabetic effects in diet-induced diabetic mice and Lepr(db/db) mice. Saha PK; Reddy VT; Konopleva M; Andreeff M; Chan L J Biol Chem; 2010 Dec; 285(52):40581-92. PubMed ID: 20956520 [TBL] [Abstract][Full Text] [Related]
15. The effect of ex vivo CDDO-Me activation on nuclear factor erythroid 2-related factor 2 pathway in white blood cells from patients with septic shock. Noel S; Zheng L; Navas-Acien A; Fuchs RJ Shock; 2014 Nov; 42(5):392-9. PubMed ID: 25105464 [TBL] [Abstract][Full Text] [Related]
17. Neuroprotective effect of Nrf2/ARE activators, CDDO ethylamide and CDDO trifluoroethylamide, in a mouse model of amyotrophic lateral sclerosis. Neymotin A; Calingasan NY; Wille E; Naseri N; Petri S; Damiano M; Liby KT; Risingsong R; Sporn M; Beal MF; Kiaei M Free Radic Biol Med; 2011 Jul; 51(1):88-96. PubMed ID: 21457778 [TBL] [Abstract][Full Text] [Related]
18. Identification and quantification of the basal and inducible Nrf2-dependent proteomes in mouse liver: biochemical, pharmacological and toxicological implications. Walsh J; Jenkins RE; Wong M; Olayanju A; Powell H; Copple I; O'Neill PM; Goldring CE; Kitteringham NR; Park BK J Proteomics; 2014 Aug; 108(100):171-87. PubMed ID: 24859727 [TBL] [Abstract][Full Text] [Related]
19. c-Jun NH2-terminal kinase-mediated up-regulation of death receptor 5 contributes to induction of apoptosis by the novel synthetic triterpenoid methyl-2-cyano-3,12-dioxooleana-1, 9-dien-28-oate in human lung cancer cells. Zou W; Liu X; Yue P; Zhou Z; Sporn MB; Lotan R; Khuri FR; Sun SY Cancer Res; 2004 Oct; 64(20):7570-8. PubMed ID: 15492284 [TBL] [Abstract][Full Text] [Related]
20. The triterpenoid CDDO limits inflammation in preclinical models of cystic fibrosis lung disease. Nichols DP; Ziady AG; Shank SL; Eastman JF; Davis PB Am J Physiol Lung Cell Mol Physiol; 2009 Nov; 297(5):L828-36. PubMed ID: 19700644 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]